S&P 500
7,401.60
+0.01%
Dow Jones
51,800.00
-0.11%
Nasdaq 100
29,524.40
-0.02%
Russell 2000
2,980.93
-0.04%
FTSE 100
10,438.20
-0.23%
Nikkei 225
69,337.20
+0.03%

Personal Finance

MOR logo Morphosys AG : MOR

MOR

Stock Data

$18.96

Change up

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

MorphoSys AG is a biopharmaceutical company based in Germany, focused on developing therapeutic antibodies for cancer and autoimmune diseases. It has brought to market Tafasitamab for B cell malignancies and is working on treatments for conditions like myelofibrosis, autoimmune diseases, Alzheimer’s, and rheumatoid arthritis. The company collaborates globally, including partnerships for developing and commercializing its products in various regions. Founded in 1992, MorphoSys stands out for its commitment to addressing unmet medical needs through innovative therapies.

All MOR Articles

0 Articles

No articles found for MOR.